Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.To support HIV research and the accuracy of HIV Testing
Subscribe to our email newsletter
SeraCare Life Sciences has announced that the company has been awarded two new contracts from the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) and that a third existing contract has been expanded by the NIH to support federally-funded HIV research and testing. These contracts represent a combined $10.8m in new funding if all options are exercised over the life of the contracts.
Under a new contract awarded by the Centers for Disease Control (CDC), SeraCare will support efforts to ensure that laboratories performing HIV-1 assays are achieving accurate results. The company will provide well characterised HIV-1 positive and negative plasma and will test, dispense and distribute panels to approximately 650 laboratories participating in this performance evaluation program, which is used as a self-assessment tool for facilities performing HIV-1 rapid testing. The five-year contract is valued at over $3.6m if all options are exercised by the CDC.
Under a second new contract awarded by PPD to support the NIH’s Division for HIV Clinical Research Support Services, SeraCare will collect, characterise, assemble and distribute a comprehensive panel of current worldwide HIV strains. The 15 month contract is valued at $2m.
Under an expanded, existing contract with the NIH, SeraCare will support the growth of the repository and quality control the historic AIDS and AIDS-related studies in the collection in preparation for anticipated broader use. The $5.2m expansion increases the remaining value of the contract over the next two years to $6.3m.
Susan Vogt, president and CEO of SeraCare Life Sciences, said: “The government sector is an important customer of our services business and these recent awards demonstrate SeraCare’s fundamental role in the support of government-sponsored research projects and, specifically, our leadership position in providing the highest quality services in support of HIV research and testing. Moreover, we believe these types of projects may increase given the influx of federal stimulus dollars for government sponsored research.”